Navigation Links
Tandem Diabetes Care Prices Initial Public Offering
Date:11/13/2013

SAN DIEGO, Nov. 13, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem"), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the pricing of its initial public offering of 8,000,000 shares of common stock at a price of $15.00 per share.  In addition, Tandem has granted the underwriters a 30-day  option to purchase up to an additional 1,200,000 shares at the initial public offering price.  All of the shares are being offered by Tandem. The shares are expected to begin trading tomorrow, November 14, 2013, on the NASDAQ Global Market under the ticker symbol "TNDM." The offering is expected to close on November 19, 2013, pending customary closing conditions.

BofA Merrill Lynch and Piper Jaffray are acting as joint book-running managers for the offering. Deutsche Bank Securities and Stifel are acting as co-managers.  

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (SEC) on November 13, 2013. When available, copies of the final prospectus may be obtained from: BofA Merrill Lynch, 222 Broadway, New York, NY 10038 Attention: Prospectus Department, by email at dg.Prospectus_Requests@baml.com; or Piper Jaffray & Co., Attention: Equity Capital Markets, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at 800-747-3924 or by email at prospectus@pjc.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company manufactures and sells the t:slim Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the first and only insulin pump with a high resolution, color touch screen. Tandem is based in San Diego, California.


'/>"/>
SOURCE Tandem Diabetes Care, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TANDEM DIABETES CARE BECOMES PRESENTING SPONSOR OF THE GREATEST AWARDS SHOW IN DIABETES
2. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
3. Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
4. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
5. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
6. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
7. Organogenesis Launches Fight4MyFeet for Diabetes Patient and Healthcare Provider Communities
8. The Diabetes and Sleep Apnea Connection
9. New Tech Tools Help Fight Diabetes
10. JDRF Teams Up with Pfizers Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes
11. T1D Exchange Awarded $2.8M Grant by JDRF to Study Metformin and Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... May 23, 2016 Experts from ... Precision Medicine and the role of technology in ... The First International Conference of VPS-Penn Medicine opened ... patronage and presence of Sheikh Nahyan bin Mubarak Al Nahyan, ... Precision Medicine, which helps provide personalized medicine and tailor-made healthcare ...
(Date:5/22/2016)... DS Biopharma (DS) today ... compound DS102 in chronic obstructive pulmonary disease (COPD) ... patients. Recent DS preclinical data suggests ... and has bronchodilatory, anti-inflammatory and anti-fibrotic properties in ... will publish further detail on these findings later ...
Breaking Medicine Technology:
(Date:5/25/2016)... CA (PRWEB) , ... May 25, 2016 , ... "FCPX ... the quality of your footage," said Christina Austin - CEO of Pixel Film Studios. ... editors can quickly and easily add stylish color grades to their footage. A LUT ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Consumer access ... In early June 2016, Kashi®, a maker of whole grain cereals and other plant-based ... Certified Transitional ingredient: hard red winter wheat processed by Hesco/Dakota Organic Products. , ...
(Date:5/25/2016)... ... , ... Stern Environmental Group , of Secaucus, New Jersey, working in ... Stern’s Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first ... for use in dormitories, shelters, and nursing homes for real time bedbug monitoring in ...
(Date:5/24/2016)... ... May 24, 2016 , ... Sterling Global Products is launching ... and patented refillable hanging wipe dispenser. The campaign kick-off video is located via this ... June 25, 2016. The goal is to raise $1,000 per day for a total ...
(Date:5/24/2016)... ... May 24, 2016 , ... To better understand the impact ... award to examine gender differences in lung cancer. Today, the Lung Association announced Sharad ... Cancer in Women Award, funded by the American Lung Association’s LUNG FORCE initiative, which ...
Breaking Medicine News(10 mins):